Article
EPIDEMIOLOGY OF LEVODOPA-INDUCED DYSKINESIA: PREVALENCE AND ASSOCIATED CLINICAL FACTORS IN LATIN AMERICA
2025-08-27
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Although levodopa remains the gold standard treatment for Parkinson’s disease (PD), its chronic use is associated with levodopa-induced dyskinesia (LID), a motor complication that impacts prognosis, quality of life, and treatment costs. Most known LID-associated factors have been identified in European-descendant populations. <h4>Objectives</h4> To describe the epidemiology...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6e502bd2-05a3-59d1-b68f-f34448f0c113
- DOI
- 10.1101/2025.08.25.25334104
